Form 4 for CRL Charles River Laboratories

Accepted 2022-02-01 00:00:00 ET · period of report 2021-10-26 · accession 0001127602-22-002789 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
	2022-02-01	2022-01-28	CRL	FOSTER JAMES C	COB, Pres, CEO, Dir	A - Grant	$0.00	+65.0K	263.5K	+33%	$0
I	2022-02-01	2021-10-26	CRL	FOSTER JAMES C	COB, Pres, CEO, Dir	G - Gift	$0.00	-14.8K	0	-100%	$0
	2022-02-01	2022-01-28	CRL	FOSTER JAMES C	COB, Pres, CEO, Dir	F - Tax	$312.24	-25.1K	238.4K	-10%	-$7.84M

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-01-28	A	A	65,011	$0.00	263,510	D	—	—	(F3) Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on February 22, 2019. (F4) On 11/18/2021, the reporting person contributed 8,000 shares of CRL Common Stock to a grantor retained annuity trust for the benefit of himself and his adult children.
2	Common	Common Stock	2021-10-26	G	D	14,813	$0.00	0	I 2019 GRAT	—	—	(F1) On 10/26/2021: 14,813 shares were gifted from the 2019 GRAT account to Mr. Foster's children. (F2) On 10/26/2021: 4,200 shares were transferred from the 2019 GRAT account to Direct Holdings.
3	Common	Common Stock	2022-01-28	F	D	25,108	$312.24	238,402	D	—	—	(F4) On 11/18/2021, the reporting person contributed 8,000 shares of CRL Common Stock to a grantor retained annuity trust for the benefit of himself and his adult children.